Page last updated: 2024-09-04

4-methoxyhonokiol and Diabetic Glomerulosclerosis

4-methoxyhonokiol has been researched along with Diabetic Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, L; Cai, L; Guo, H; Kim, KS; Kim, KT; Lian, X; Ma, T; Rane, MJ; Zhang, Z; Zheng, Z1

Other Studies

1 other study(ies) available for 4-methoxyhonokiol and Diabetic Glomerulosclerosis

ArticleYear
4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
    Toxicology and applied pharmacology, 2019, 05-01, Volume: 370

    Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, High-Fat; Enzyme Activation; Fatty Acids; Insulin Resistance; Kidney; Lignans; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Phytotherapy

2019